Simplex Trading’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.23K Sell
130
-14,151
-99% -$464K ﹤0.01% 7998
2025
Q4
$453K Buy
+14,281
New +$429K ﹤0.01% 3397
2025
Q3
Sell
-1,072
Closed -$18.4K 10026
2025
Q2
$12K Sell
1,072
-1,185
-53% -$11.3K ﹤0.01% 7198
2025
Q1
$15K Buy
2,257
+776
+52% +$7.24K ﹤0.01% 6807
2024
Q4
$16K Sell
1,481
-1,157
-44% -$14.2K ﹤0.01% 6872
2024
Q3
$32K Sell
2,638
-2,089
-44% -$29.6K ﹤0.01% 6307
2024
Q2
$63K Buy
4,727
+3,571
+309% +$48.2K ﹤0.01% 5848
2024
Q1
$15K Sell
1,156
-6,823
-86% -$41.3K ﹤0.01% 7340
2023
Q4
$41K Buy
7,979
+5,298
+198% +$22.6K ﹤0.01% 6282
2023
Q3
$10K Sell
2,681
-47,874
-95% -$315K ﹤0.01% 7197
2023
Q2
$537K Buy
+50,555
New +$538K ﹤0.01% 3234
2023
Q1
Sell
-10,658
Closed -$96.2K 10095
2022
Q4
$98K Buy
+10,658
New +$111K ﹤0.01% 5102
2021
Q4
Sell
-222
Closed -$7K 11385
2021
Q3
$7K Hold
222
﹤0.01% 9135
2021
Q2
$7K Sell
222
-439
-66% -$15.5K ﹤0.01% 9305
2021
Q1
$25K Buy
+661
New +$37.6K ﹤0.01% 7279
2020
Q4
Sell
-1,202
Closed -$55.1K 9057
2020
Q3
$40K Buy
1,202
+732
+156% +$20.9K ﹤0.01% 5831
2020
Q2
$11K Buy
470
+97
+26% +$2.3K ﹤0.01% 6612
2020
Q1
$8K Buy
+373
New +$9.22K ﹤0.01% 6622

Other funds holding STOK

Simplex Trading's STOK Position: Q1 2026 in Review

Simplex Trading reduced its Stoke Therapeutics (STOK) stake by 99% in Q1 2026, selling an estimated $464K and leaving 130 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7998.

Simplex Trading first reported a position in STOK in Q1 2020 and has held it in 18 quarters since. The position peaked at $537K in Q2 2023. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Simplex Trading held 130 shares of Stoke Therapeutics worth $4.23K as of Q1 2026.
  • Simplex Trading sold 14,151 Stoke Therapeutics shares in Q1 2026, an estimated $464K.
  • Stoke Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7998 holding.
  • Simplex Trading first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • Simplex Trading's Stoke Therapeutics position peaked at $537K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.